|
DSCR3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.28989999792495E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.95049999777098E-08 |
| Normal-vs-Stage2 |
3.181500E-03 |
| Normal-vs-Stage3 |
1.247180E-04 |
| Normal-vs-Stage4 |
5.93509999999853E-05 |
| Stage1-vs-Stage2 |
8.014800E-01 |
| Stage1-vs-Stage3 |
6.629800E-01 |
| Stage1-vs-Stage4 |
4.201400E-01 |
| Stage2-vs-Stage3 |
5.921400E-01 |
| Stage2-vs-Stage4 |
3.606200E-01 |
| Stage3-vs-Stage4 |
6.287800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.90919999201833E-09 |
| Normal-vs-AfricanAmerican |
1.227090E-04 |
| Normal-vs-Asian |
2.727800E-01 |
| Caucasian-vs-AfricanAmerican |
1.662250E-01 |
| Caucasian-vs-Asian |
6.160000E-01 |
| AfricanAmerican-vs-Asian |
9.955400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.55640003504953E-09 |
| Normal-vs-Female |
3.62350000000511E-05 |
| Male-vs-Female |
2.128400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.64619999998283E-06 |
| Normal-vs-Extreme_Weight |
1.70359948370447E-10 |
| Normal-vs-Obese |
6.22759999999722E-05 |
| Normal-vs-Extreme_Obese |
5.614400E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.446800E-01 |
| Normal_Weight-vs-Obese |
3.194800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.269400E-01 |
| Extreme_Weight-vs-Obese |
3.735800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.578000E-01 |
| Obese-vs-Extreme_Obese |
9.258200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.84125999999063E-05 |
| Normal-vs-Age(41-60Yrs) |
3.13150000041951E-07 |
| Normal-vs-Age(61-80Yrs) |
2.37149999637865E-08 |
| Normal-vs-Age(81-100Yrs) |
1.164470E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.202000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.569200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.895800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.097000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.384200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.945200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.88839999193391E-09 |
| Normal-VS-Type2 PRCC |
1.741580E-03 |
| Normal-VS-KIRP CIMP |
6.14669999999817E-05 |
| Normal-VS-Unclassified PRCC |
2.629700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.370400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.307200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.656400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.516820E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.248000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.703200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.37699999975305E-07 |
| Normal-vs-N1 |
5.79720000000172E-05 |
| Normal-vs-N2 |
7.99770000000644E-05 |
| N0-vs-N1 |
9.084800E-01 |
| N0-vs-N2 |
3.006800E-01 |
| N1-vs-N2 |
2.880800E-01 |
|
|
